Some of the most prominent names in biotechnology plunged on Thursday as the Nasdaq headed for its worst day in nearly two years.
Read MoreThe latest on the markets
Jim Cramer sees that the market worships three huge cult stocks—and he totally gets it.
The market closed lower Tuesday, but veteran strategist John Manley said he doesn't believe this is the top of the cycle.
Jim Cramer speaks to the CEO of this private top-rated tequila company that just bagged a $100 million deal.
As long as the Federal Reserve keeps interest rates low, stock values will remain elevated, strategist Michael Farr said.
Get the best of CNBC in your inbox